The Third Generation Of TPO Mimetics Are Again Biologics
pharmacy / pharmacist
After failure of 1st generation thrombopoietic growth factors due to immunogencity, the 2nd generation is focused on oral TPO mimetics, now followed by a 3rd generation of engineered biologics with potential for higher potency and efficacy The Business Intelligence firm La Merie S.L.